Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jacobs

Showing results (681-690 of 3,722) with videos related to

Pageof 373
Sort By:
Molecular Cell|July 6, 2000
A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosisM S Glickman, J S Cox, W R Jacobs
Cancer Causes & Control : CCC|January 26, 2002
Whole and refined grain intake and risk of incident postmenopausal breast cancer (United States)K K Nicodemus, D R Jacobs, A R Folsom
Antimicrobial Agents and Chemotherapy|March 26, 2003
Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agentsKim L Credito, Michael R Jacobs, Peter C Appelbaum
The Journal of Antimicrobial Chemotherapy|September 1, 1990
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centresM R Jacobs, S K Spangler, P C Appelbaum
Public Opinion Quarterly|March 4, 1994
Medical care in the United States--an updateL R Jacobs, R Y Shapiro, E C Schulman
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniaeL M Kelly, M R Jacobs, P C Appelbaum
Clinical Oral Implants Research|February 13, 2001
The clinical use of deproteinized bovine bone mineral on bone regeneration in conjunction with immediate implant installationD van Steenberghe, A Callens, L Geers, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1983
Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitisD J Tweardy, M R Jacobs, W T Speck
The Journal of Laryngology and Otology|October 1, 1995
Ameloblastic carcinoma of the maxillaC M Lolachi, S K Madan, J R Jacobs
Antimicrobial Agents and Chemotherapy|December 1, 1994
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinirS K Spangler, M R Jacobs, P C Appelbaum
Pageof 373

Showing results (681-690 of 3,722) with videos related to

Sort By:
Pageof 373
Molecular Cell|July 6, 2000
A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosisM S Glickman, J S Cox, W R Jacobs
Cancer Causes & Control : CCC|January 26, 2002
Whole and refined grain intake and risk of incident postmenopausal breast cancer (United States)K K Nicodemus, D R Jacobs, A R Folsom
Antimicrobial Agents and Chemotherapy|March 26, 2003
Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agentsKim L Credito, Michael R Jacobs, Peter C Appelbaum
The Journal of Antimicrobial Chemotherapy|September 1, 1990
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centresM R Jacobs, S K Spangler, P C Appelbaum
Public Opinion Quarterly|March 4, 1994
Medical care in the United States--an updateL R Jacobs, R Y Shapiro, E C Schulman
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniaeL M Kelly, M R Jacobs, P C Appelbaum
Clinical Oral Implants Research|February 13, 2001
The clinical use of deproteinized bovine bone mineral on bone regeneration in conjunction with immediate implant installationD van Steenberghe, A Callens, L Geers, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1983
Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitisD J Tweardy, M R Jacobs, W T Speck
The Journal of Laryngology and Otology|October 1, 1995
Ameloblastic carcinoma of the maxillaC M Lolachi, S K Madan, J R Jacobs
Antimicrobial Agents and Chemotherapy|December 1, 1994
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinirS K Spangler, M R Jacobs, P C Appelbaum
Pageof 373